Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Angell

Showing results (81-90 of 164) with videos related to

Pageof 17
Sort By:
Language, Speech, and Hearing Services in Schools|April 18, 2006
Family members' perceptions of augmentative and alternative communication device useRita L Bailey, Howard P Parette, Julia B Stoner, et al.
Thyroid : Official Journal of the American Thyroid Association|April 5, 2014
In search of an unstimulated thyroglobulin baseline value in low-risk papillary thyroid carcinoma patients not receiving radioactive iodine ablationTrevor E Angell, Carole A Spencer, Barbara D Rubino, et al.
The Journal of Biological Chemistry|August 5, 2000
Identification of GRIM-19, a novel cell death-regulatory gene induced by the interferon-beta and retinoic acid combination, using a genetic approachJ E Angell, D J Lindner, P S Shapiro, et al.
Calcified Tissue International|March 25, 1999
Calcidiol and PTH levels in women attending an osteoporosis programS T Haden, G E Fuleihan, J E Angell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitroTrevor E Angell, Melissa G Lechner, Julie K Jang, et al.
Thyroid : Official Journal of the American Thyroid Association|March 1, 2023
Malignancy Risk of Thyroid Nodules That Are Not Classifiable by the American Thyroid Association Ultrasound Risk Stratification System: A Systematic Review and Meta-AnalysisDaniel Kwon, Marta Kulich, Wendy J Mack, et al.
BMC Medicine|January 29, 2016
Long- versus short-interval follow-up of cytologically benign thyroid nodules: a prospective cohort studyMarco Medici, Xiaoyun Liu, Norra Kwong, et al.
Journal of Abnormal Psychology|March 20, 1998
Development of depression from preadolescence to young adulthood: emerging gender differences in a 10-year longitudinal studyB L Hankin, L Y Abramson, T E Moffitt, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 7, 2018
POSITIVE THYROTROPIN RECEPTOR ANTIBODIES IN PATIENTS WITH TRANSIENT THYROTOXICOSISTrevor E Angell, Olivia Van Benschoten, David A Cohen, et al.
The Oncologist|September 1, 2020
Changes in Stage Distribution and Disease-Specific Survival in Differentiated Thyroid Cancer with Transition to American Joint Committee on Cancer 8th Edition: A Systematic Review and Meta-AnalysisMelissa G Lechner, Angeli C Bernardo, Alyssa Lampe, et al.
Pageof 17

Showing results (81-90 of 164) with videos related to

Sort By:
Pageof 17
Language, Speech, and Hearing Services in Schools|April 18, 2006
Family members' perceptions of augmentative and alternative communication device useRita L Bailey, Howard P Parette, Julia B Stoner, et al.
Thyroid : Official Journal of the American Thyroid Association|April 5, 2014
In search of an unstimulated thyroglobulin baseline value in low-risk papillary thyroid carcinoma patients not receiving radioactive iodine ablationTrevor E Angell, Carole A Spencer, Barbara D Rubino, et al.
The Journal of Biological Chemistry|August 5, 2000
Identification of GRIM-19, a novel cell death-regulatory gene induced by the interferon-beta and retinoic acid combination, using a genetic approachJ E Angell, D J Lindner, P S Shapiro, et al.
Calcified Tissue International|March 25, 1999
Calcidiol and PTH levels in women attending an osteoporosis programS T Haden, G E Fuleihan, J E Angell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitroTrevor E Angell, Melissa G Lechner, Julie K Jang, et al.
Thyroid : Official Journal of the American Thyroid Association|March 1, 2023
Malignancy Risk of Thyroid Nodules That Are Not Classifiable by the American Thyroid Association Ultrasound Risk Stratification System: A Systematic Review and Meta-AnalysisDaniel Kwon, Marta Kulich, Wendy J Mack, et al.
BMC Medicine|January 29, 2016
Long- versus short-interval follow-up of cytologically benign thyroid nodules: a prospective cohort studyMarco Medici, Xiaoyun Liu, Norra Kwong, et al.
Journal of Abnormal Psychology|March 20, 1998
Development of depression from preadolescence to young adulthood: emerging gender differences in a 10-year longitudinal studyB L Hankin, L Y Abramson, T E Moffitt, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 7, 2018
POSITIVE THYROTROPIN RECEPTOR ANTIBODIES IN PATIENTS WITH TRANSIENT THYROTOXICOSISTrevor E Angell, Olivia Van Benschoten, David A Cohen, et al.
The Oncologist|September 1, 2020
Changes in Stage Distribution and Disease-Specific Survival in Differentiated Thyroid Cancer with Transition to American Joint Committee on Cancer 8th Edition: A Systematic Review and Meta-AnalysisMelissa G Lechner, Angeli C Bernardo, Alyssa Lampe, et al.
Pageof 17